SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0000950103-21-018083
Filing Date
2021-11-18
Accepted
2021-11-18 17:31:34
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM SC TO-C dp161916_sctoc.htm SC TO-C 25186
2 EXHIBIT 99.1 dp161916_ex9901.htm EX-99.1 37818
3 GRAPHIC image_001.jpg GRAPHIC 50153
4 GRAPHIC image_002.jpg GRAPHIC 258099
5 EXHIBIT 99.2 dp161916_ex9902.htm EX-99.2 8546
6 GRAPHIC image_003.jpg GRAPHIC 15589
7 GRAPHIC image_004.jpg GRAPHIC 15125
8 GRAPHIC image_005.jpg GRAPHIC 21821
  Complete submission text file 0000950103-21-018083.txt   570642
Mailing Address NOVO ALLE DK 2880 BAGSVAERD DENMARK G7 00000
Business Address NOVO ALLE DK 2880 BAGSVAERD DENMARK G7 00000 4544448888
NOVO NORDISK A S (Filed by) CIK: 0000353278 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Subject) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-87866 | Film No.: 211425642
SIC: 2834 Pharmaceutical Preparations